SNN (Smith & Nephew plc) Stock Financials & Earnings | Market Cap Arena

SNN (Smith & Nephew plc) Stock Financials & Earnings | Market Cap Arena

SNNSmith & Nephew plc

Mkt Cap$15B

Healthcare·Medical - Devices·🇬🇧 United Kingdom·NYSE

Revenue (TTM)$12.0B

Net Income (TTM)$1.0B

EPS (TTM)$2.40

Free Cash Flow (TTM)$1.5B

Gross Margin68.8%

Op. Margin13.9%

Net Margin8.7%

FCF Margin12.2%

P/S Ratio (TTM)1.2x

P/E Ratio (TTM)14.0x

YoY Rev Growth+11.4%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q2 20	$2.0B	$1.4B	-$5M
Q4 20	$2.5B	$1.8B	$438M
Q2 21	$2.6B	$1.8B	$239M
Q4 21	$2.6B	$1.9B	$473M
Q2 22	$2.6B	$1.8B	$242M
Q4 22	$2.6B	$1.9B	$423M
Q2 23	$2.7B	$1.9B	$275M
Q4 23	$2.8B	$2.0B	$407M
Q2 24	$2.8B	$2.0B	$328M
Q4 24	$3.0B	$2.1B	$329M
Q2 25	$3.0B	$2.1B	$435M
Q4 25	$3.2B	$2.1B	$570M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q2 20	1.5x	13.3x
Q4 20	1.5x	13.8x
Q2 21	1.5x	15.4x
Q4 21	1.5x	14.9x
Q2 22	1.4x	13.8x
Q4 22	1.4x	19.4x
Q2 23	1.4x	20.3x
Q4 23	1.3x	29.9x
Q2 24	1.3x	27.8x
Q4 24	1.3x	21.5x
Q2 25	1.2x	18.2x
Q4 25	1.2x	14.0x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 20	$73M	-$115M
Q4 20	$862M	$607M
Q2 21	$363M	$188M
Q4 21	$514M	$281M
Q2 22	$207M	$34M
Q4 22	$261M	$76M
Q2 23	$113M	-$54M
Q4 23	$495M	$235M
Q2 24	$238M	$66M
Q4 24	$749M	$540M
Q2 25	$400M	$259M
Q4 25	$888M	$595M

Capital Expenditures

CapEx

Quarter	CapEx
Q2 20	$188M
Q4 20	$255M
Q2 21	$175M
Q4 21	$233M
Q2 22	$173M
Q4 22	$185M
Q2 23	$167M
Q4 23	$260M
Q2 24	$172M
Q4 24	$209M
Q2 25	$140M
Q4 25	$294M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 20	-16.6%	-1.4%
Q4 20	+2.5%	+12.2%
Q2 21	+4.6%	+14.2%
Q4 21	-1.5%	+2.3%
Q2 22	+27.8%	+15.6%
Q4 22	+3.6%	+5.0%
Q2 23	+5.2%	+4.2%
Q4 23	+7.7%	+12.5%
Q2 24	+8.7%	+6.0%
Q4 24	+14.1%	+21.1%
Q2 25	+9.3%	+3.8%
Q4 25	+13.3%	+8.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 20	$15M	0.7%
Q4 20	$11M	0.4%
Q2 21	$23M	0.9%
Q4 21	$18M	0.7%
Q2 22	$23M	0.9%
Q4 22	$17M	0.7%
Q2 23	$19M	0.7%
Q4 23	$20M	0.7%
Q2 24	$20M	0.7%
Q4 24	$20M	0.7%
Q2 25	$0	0.0%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q2 20	$148M	$1.2B
Q4 20	$195M	$1.2B
Q2 21	$171M	$1.4B
Q4 21	$226M	$1.3B
Q2 22	$174M	$1.4B
Q4 22	$222M	$1.3B
Q2 23	$166M	$1.5B
Q4 23	$219M	$1.4B
Q2 24	$137M	$1.5B
Q4 24	$152M	$1.6B
Q2 25	$144M	$1.5B
Q4 25	$152M	$1.4B

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 20	$347M	$0	$347M
Q4 20	$1.8B	$0	$1.8B
Q2 21	$1.4B	$0	$1.4B
Q4 21	$1.3B	$0	$1.3B
Q2 22	$516M	$0	$516M
Q4 22	$350M	$0	$350M
Q2 23	$190M	$0	$190M
Q4 23	$302M	$0	$302M
Q2 24	$568M	$0	$568M
Q4 24	$619M	$0	$619M
Q2 25	$675M	$0	$675M
Q4 25	$557M	$0	$557M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q2 20	877M	+0.1%
Q4 20	880M	+0.4%
Q2 21	880M	-0.1%
Q4 21	878M	-0.2%
Q2 22	876M	-0.2%
Q4 22	870M	-0.7%
Q2 23	873M	+0.4%
Q4 23	873M	-0.0%
Q2 24	437M	-50.0%
Q4 24	440M	+0.7%
Q2 25	440M	+0.0%
Q4 25	436M	-0.8%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$330K	14K
FY 15	$316K	15K
FY 16	$300K	16K
FY 17	$292K	16K
FY 18	$294K	17K
FY 19	$285K	18K
FY 20	$245K	19K
FY 21	$275K	19K
FY 22	$273K	19K
FY 23	$291K	19K
FY 24	$322K	18K
FY 25	$342K	18K